1. AB0089 Histopathological change caused by biological treatment in rheumatoid arthritis synovial tissue. (12th June 2018) Authors: Kubota, A.; Suguro, T.; Nakajima, A.; Masayuki, S.; Masato, S.; Kentaro, T.; Kazuaki, T. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0204 Radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs (BDMARDS) and its predictive factors: results of 3 to 4 years follow-up. (12th June 2018) Authors: Nakajima, A.; Terayama, K.; Sonobe, M.; Takahashi, H.; Akatsu, Y.; Taniguchi, S.; Yamada, M.; Nakagawa, K. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0211 Which Disease Activity Score 28 (DAS28) Based Flare Criteria Impact on Functional Disability in Patients with Ra in Das28 Remission State Using The IORRA Cohort. (15th July 2016) Authors: Shidara, K.; Tanaka, E.; Inoue, E.; Yamaguchi, R.; Shimizu, Y.; Hoshi, D.; Sugimoto, N.; Nakajima, A.; Momohara, S.; Taniguchi, A.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0224 Difficulty in Maintaining Full Physical Function for 10 Years in Patients with Early Rheumatoid Arthritis in Daily Clinical Practice. Analysis of the Iorra Cohort. (10th June 2014) Authors: Nakajima, A.; Inoue, E.; Shimizu, Y.; Kobayashi, A.; Shidara, K.; Seto, Y.; Hoshi, D.; Sugimoto, N.; Tanaka, E.; Taniguchi, A.; Momohara, S.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 877 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0257 ASSESSMENT OF PHYSICAL DYSFUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO PLANNED PREGNANCY FROM THE IORRA COHORT. (13th June 2020) Authors: Ochiai, M.; Tanaka, E.; Inoue, E.; Abe, M.; Sugano, E.; Sugitani, N.; Saka, K.; Yoko, H.; Yamaguchi, R.; Sugimoto, N.; Katsunori, I.; Nakajima, A.; Taniguchi, A.; Yamanaka, H.; Harigai, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0308 Optimal timing for tocilizumab administration to patients with rheumatoid arthritis in japan based on a cost-effectiveness analysis using the iorra cohort study. (23rd January 2014) Authors: Tanaka, E.; Inoue, E.; Hoshi, D.; Shidara, K.; Sato, E.; Inoue, Y.; Seto, Y.; Nakajima, A.; Momohara, S.; Taniguchi, A.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A881 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0387 Incidence and Risk Factors for Tuberculosis in Japanese Patients with Rheumatoid Arthritis During a 12-Year Observational Period Using the Iorra Cohort. (9th June 2015) Authors: Yamaguchi, R.; Shidara, K.; Tanaka, E.; Inoue, E.I.; Shimizu, Y.; Kobayashi, A.; Sugimoto, N.; Hoshi, D.; Sato, E.; Seto, Y.; Nakajima, A.; Momohara, S.; Taniguchi, A.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1022 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB0528 Cost-effectiveness of a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, tocilizumab, in rheumatoid arthritis using IORRA cohort database. (23rd January 2014) Authors: Tanaka, E.; Inoue, E.; Hoshi, D.; Kobayashi, A.; Sugimoto, N.; Shidara, K.; Sato, E.; Seto, Y.; Nakajima, A.; Momohara, S.; Taniguchi, A.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Can CuFeS2 be used in a sensitized thermal cell?. (September 2020) Authors: Sekiya, H.; Isobe, T.; Nakajima, A.; Matsushita, S. Journal: Materials today energy Issue: Volume 17(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region—the GO ASIA initiative. Issue 6 (14th January 2018) Authors: Chan, W.‐K.; Treeprasertsuk, S.; Imajo, K.; Nakajima, A.; Seki, Y.; Kasama, K.; Kakizaki, S.; Fan, J.‐G.; Song, M. J.; Yoon, S. K.; Dan, Y.‐Y.; Lesmana, L.; Ho, K.‐Y.; Goh, K.‐L.; Wong, V. W.‐S. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 6(2018) Page Start: 816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗